Mostrando 10 resultados de: 10
Publisher
Archivos Venezolanos de Farmacologia y Terapeutica(6)
Revista Latinoamericana de Hipertension(3)
Cardiology Research and Practice(1)
Área temáticas
Enfermedades(7)
Farmacología y terapéutica(6)
Medicina y salud(4)
Fisiología humana(2)
Bioquímica(1)
C-reactive protein: Clinical and epidemiological perspectives
ReviewAbstract: An important etiopathogenic component of cardiovascular disease is atherosclerosis, with inflammatioPalabras claves:Autores:Añez-Ramos R., Apruzzese V., Chávez-Castillo M., Martínez M.S., Rojas-Quintero J., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore BermúdezFuentes:scopusFront-line medicines used in the treatment of tuberculosis
ArticleAbstract: Tuberculosis has emerged as an enormous global public health epidemic. Worldwide, it is the second lPalabras claves:Estreptomicin, Ethambutol, isoniazid, M. Tuberculosis, Pyrazinamide, rifampinAutores:Arráiz N., Bermúdez F.A., Leal E.M., Rodriguez M., Silva C., Valdelamar L., Valmore BermúdezFuentes:scopusIncrease of malondialdehido and nitric oxide in COPD patients
ArticleAbstract: Introduction: Chronic Obstructive Pulmonary Disease (COPD) is an entity characterized by the persistPalabras claves:Chronic obstructive pulmonary disease, Malondialdehyde, Nitric oxide, Oxidative profileAutores:Bello L.M., Linares S., Silva C., Valmore BermúdezFuentes:scopusInsulinoma associated with pituitary adenoma: A potential case of sporadic nem-1? A case study
ArticleAbstract: Insulinomas are neuroendocrine tumors derived from insulin-producing β cells located in pancreatic iPalabras claves:hyperinsulinemia, Hypoglycemia, Insulinoma, MEN-1, PROLACTINOMAAutores:Arias V., Awad A.A., Chávez C., David A., García C., Garicano C.M.D., Miquilena E., Molero F., Rojas-Quintero J., Silva C., Valmore Bermúdez, Velasco M., Vera M.Fuentes:scopusMolecular biology of glucose transporters: Classification, structure and distribution
ReviewAbstract: Hexoses like glucose, galactose and fructose serve as basic fuel molecules for eucaryotic cells. ThePalabras claves:Co-transporter, Facilitative diffusion, glucose, Glut, SGLT-1, SGLT-2, TransporterAutores:Acosta A., Amell A., Andara C., Añez J., Angulo V., Arráiz N., Bermúdez F.A., Carrillo M., Leal E.M., Linares S., Martins G., Mengual-Moreno E., Rodriguez M., Seyfi H.A., Silva C., Valdelamar L., Valmore BermúdezFuentes:scopusPharmacologic treatment of obesity: Present, past and future
ReviewAbstract: Obesity is a chronic, stigmatized and costly disease that is rarely curable and is increasing in prePalabras claves:body mass index, Energetic balance, Noradrenegic agents, obesity, Orlistat, Serotoninergic agents, SibutraminAutores:Amell A., Bermúdez F.A., Cabrera M., Leal E.M., Mengual-Moreno E., Rodriguez M., Silva C., Toledo A., Valdelamar L., Valmore BermúdezFuentes:scopusLipid profile reference intervals in individuals from Maracaibo, Venezuela: An insight from the Maracaibo City Metabolic Syndrome prevalence study
ArticleAbstract: Objectives: Cardiovascular diseases are the main cause of death in adults worldwide. Dyslipidemias aPalabras claves:Cardiovascular disease, dyslipidemia, lipid profile, Reference intervalsAutores:Aguirre M.A., Añez-Ramos R., Angulo V., Arráiz N., Bello L.M., Carem Prieto, Fortul Y., González M.C., Linares S., Marcano R.P., Naguib A., Pacheco E., Ponce C.C., Rojas-Quintero J., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Villalobos M.Fuentes:googlescopusTumor necrosis factor as an inflammatory marker in patients with chronic obstructive pulmonary disease
ArticleAbstract: COPD is a chronic inflammatory disease that mainly affects bronchi less than 2 mm in diameter. ThisPalabras claves:Chronic obstructive pulmonary disease, Cigarette, inflammation, inflammatory mediators, Tumor necrosis factorAutores:Bello L.M., Silva C., Valmore BermúdezFuentes:scopusSerum levels of lipoprotein(a) and its behavior in the state of Zulia: 10 Years of research
ReviewAbstract: Lipoprotein Lp(a) is considered one of the most important independent risk factors for atherosclerotPalabras claves:Cardiovascular disease, Coronary artery disease, Hormone replacement therapy, lipoprotein(a), myocardial infarction, Physical activity, risk factorAutores:Amell A., Añez-Ramos R., Arias F.B., Arráiz N., Cabrera M., Cano-Ponce C., Cruz S., González M.C., Mejías J.C., Mengual-Moreno E., Nava A., Rojas-Quintero J., Silva C., Sorell G L., Souki-Rincón A., Toledo A.C., Torres W., Torres Y., Valmore BermúdezFuentes:scopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopus